These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 32451956)

  • 1. A Review of the Cholinergic System and Therapeutic Approaches to Treat Brain Disorders.
    Bertrand D; Wallace TL
    Curr Top Behav Neurosci; 2020; 45():1-28. PubMed ID: 32451956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synaptic Release of Acetylcholine Rapidly Suppresses Cortical Activity by Recruiting Muscarinic Receptors in Layer 4.
    Dasgupta R; Seibt F; Beierlein M
    J Neurosci; 2018 Jun; 38(23):5338-5350. PubMed ID: 29739869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current Progress on Central Cholinergic Receptors as Therapeutic Targets for Alzheimer's Disease.
    Nagori K; Pradhan M; Sharma M; Ajazuddin ; Badwaik HR; Nakhate KT
    Curr Alzheimer Res; 2024; 21(1):50-68. PubMed ID: 38529600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the nicotinic acetylcholine receptor in Alzheimer's disease pathology and treatment.
    Lombardo S; Maskos U
    Neuropharmacology; 2015 Sep; 96(Pt B):255-62. PubMed ID: 25514383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. α7 nicotinic acetylcholine receptors in Alzheimer's disease: neuroprotective, neurotrophic or both?
    Hernandez CM; Dineley KT
    Curr Drug Targets; 2012 May; 13(5):613-22. PubMed ID: 22300028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allosteric modulation of nicotinic receptors as a treatment strategy for Alzheimer's disease.
    Maelicke A
    Dement Geriatr Cogn Disord; 2000 Sep; 11 Suppl 1():11-8. PubMed ID: 10971047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond Acetylcholinesterase Inhibitors: Novel Cholinergic Treatments for Alzheimer's Disease.
    Kamkwalala AR; Newhouse PA
    Curr Alzheimer Res; 2017; 14(4):377-392. PubMed ID: 27697062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscarinic and nicotinic acetylcholine receptor agonists: current scenario in Alzheimer's disease therapy.
    Verma S; Kumar A; Tripathi T; Kumar A
    J Pharm Pharmacol; 2018 Aug; 70(8):985-993. PubMed ID: 29663387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive correlates of α4β2 nicotinic acetylcholine receptors in mild Alzheimer's dementia.
    Sabri O; Meyer PM; Gräf S; Hesse S; Wilke S; Becker GA; Rullmann M; Patt M; Luthardt J; Wagenknecht G; Hoepping A; Smits R; Franke A; Sattler B; Tiepolt S; Fischer S; Deuther-Conrad W; Hegerl U; Barthel H; Schönknecht P; Brust P
    Brain; 2018 Jun; 141(6):1840-1854. PubMed ID: 29672680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Nicotinic and Muscarinic Receptors on Synaptic Plasticity and Neurological Diseases.
    Fuenzalida M; Pérez MÁ; Arias HR
    Curr Pharm Des; 2016; 22(14):2004-14. PubMed ID: 26818867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotinic Cholinergic Mechanisms in Alzheimer's Disease.
    Shen J; Wu J
    Int Rev Neurobiol; 2015; 124():275-92. PubMed ID: 26472533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotinic receptor abnormalities of Alzheimer's disease: therapeutic implications.
    Nordberg A
    Biol Psychiatry; 2001 Feb; 49(3):200-10. PubMed ID: 11230871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Traced on the Timeline: Discovery of Acetylcholine and the Components of the Human Cholinergic System in a Primitive Unicellular Eukaryote Acanthamoeba spp.
    Baig AM; Rana Z; Tariq S; Lalani S; Ahmad HR
    ACS Chem Neurosci; 2018 Mar; 9(3):494-504. PubMed ID: 29058403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholinergic receptors: functional role of nicotinic ACh receptors in brain circuits and disease.
    Yakel JL
    Pflugers Arch; 2013 Apr; 465(4):441-50. PubMed ID: 23307081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in α4β2 nicotinic receptors in cognitive decline in Alzheimer's aetiopathology.
    Okada H; Ouchi Y; Ogawa M; Futatsubashi M; Saito Y; Yoshikawa E; Terada T; Oboshi Y; Tsukada H; Ueki T; Watanabe M; Yamashita T; Magata Y
    Brain; 2013 Oct; 136(Pt 10):3004-17. PubMed ID: 23975517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PET Imaging of Cholinergic Neurotransmission in Neurodegenerative Disorders.
    Tiepolt S; Meyer PM; Patt M; Deuther-Conrad W; Hesse S; Barthel H; Sabri O
    J Nucl Med; 2022 Jun; 63(Suppl 1):33S-44S. PubMed ID: 35649648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Designing Hybrids Targeting the Cholinergic System by Modulating the Muscarinic and Nicotinic Receptors: A Concept to Treat Alzheimer's Disease.
    Volpato D; Holzgrabe U
    Molecules; 2018 Dec; 23(12):. PubMed ID: 30544533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cholinergic system and spatial learning.
    Deiana S; Platt B; Riedel G
    Behav Brain Res; 2011 Aug; 221(2):389-411. PubMed ID: 21108971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allosteric modulation of nicotinic acetylcholine receptors as a treatment strategy for Alzheimer's disease.
    Maelicke A; Albuquerque EX
    Eur J Pharmacol; 2000 Mar; 393(1-3):165-70. PubMed ID: 10771010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of gene expression by muscarinic acetylcholine receptors.
    von der Kammer H; Demiralay C; Andresen B; Albrecht C; Mayhaus M; Nitsch RM
    Biochem Soc Symp; 2001; (67):131-40. PubMed ID: 11447829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.